All Resources
Announcements
Contributed Content
Expert Commentary
Garri Zmudze Insights
CONTRIBUTED CONTENT
Garri contributes op-eds and original content for leading outlets across web3, health, startups, and more.
Healthcare Digital: Deep tech is transforming our health
Digitalization like AI and blockchain will make our healthcare system more streamlined and accessible.
Contributed Content
·
20 min
·
January 15, 2023
Cointelegraph: NFTs, nonprofits and longevity intersect at Art Basel Miami
Garri interviews NFT artist Nikita Replyanski on the future of NFTs, his work with the Longevity Science Foundation, and art as community building.
Contributed Content
·
2 min
·
December 9, 2022
Cointelegraph: Why longevity matters to everyone: Living longer lives in the world of Web3
Physicians and founders are rallying behind longevity medicine, and here is what a longer, healthier human lifespan means for the crypto community.
Contributed Content
·
3 min
·
July 2, 2022
Previous
Load More
EXPERT COMMENTARY
Garri is a leading voice for trending topics in the field of health and investing.
LongeVC Backs Interface Biosciences for Advancing Inflammatory Disease Drug Development with AI-Enabled Platform
LongeVC invests in Interface Biosciences, securing $3 million for pioneering pharmaceutical development from bacterial natural products, marking a strategic advancement towards critical IND-enabling studies
Expert Commentary
·
5 min
·
Jul 27
BioSpectrum: Seeking the 'fountain of youth'
Garri founded the Longevity Science Foundation to fund the diverse treatments contributing to human longevity.
Expert Commentary
·
4 min
·
Jul 27
Sifted: Purrsonalised health: The startups and VCs betting on pet genetics
Animal genetics market revenue is predicted to exceed $6.4bn by 2027. Here are some of the pet genetics startups to watch.
Expert Commentary
·
1 min
·
Jul 27
Load More
ANNOUNCEMENT
Stay up-to-date with the latest from Garri and the companies within his realm.
Longevity.Technology: The time is right for specialist Longevity investment
Garri Zmudze, Sergey Jakimov, and Ilya Suharenko launch a new fund for longevity research: LongeVC.
Announcements
·
2 min
·
Jul 27
Longevity.Technology: Basepaws acquisition – exploring longevity beyond human health
Garri was an angel investor in pet health company Basepaws. Its acquisition offers promising insights into the future of human longevity.
Announcements
·
7 min
·
Jul 27
ARDD: Decentralized science and blockchain in aging research
Garri explains the Longevity Science Foundation's work as a nonprofit supporting a decentralized and transparent future of longevity research.
Announcements
·
4 min
·
Jul 27
Load More
ALL RESOURCES
Content at the cutting-edge of health and technology.
Longevity.Technology: The time is right for specialist Longevity investment
Garri Zmudze, Sergey Jakimov, and Ilya Suharenko launch a new fund for longevity research: LongeVC.
Announcements
·
2 min
·
Jul 27
Longevity.Technology: Basepaws acquisition – exploring longevity beyond human health
Garri was an angel investor in pet health company Basepaws. Its acquisition offers promising insights into the future of human longevity.
Announcements
·
7 min
·
Jul 27
ARDD: Decentralized science and blockchain in aging research
Garri explains the Longevity Science Foundation's work as a nonprofit supporting a decentralized and transparent future of longevity research.
Announcements
·
4 min
·
Jul 27
Forbes: Meet a VC on a mission to support women in longevity
Garri leads LongeVC to invest in diverse founders that will ensure a representative future of longevity and biotech.
Announcements
·
2 min
·
Jul 27
LongeVC Backs Interface Biosciences for Advancing Inflammatory Disease Drug Development with AI-Enabled Platform
LongeVC invests in Interface Biosciences, securing $3 million for pioneering pharmaceutical development from bacterial natural products, marking a strategic advancement towards critical IND-enabling studies
Expert Commentary
·
5 min
·
Jul 27
LongeVC Supports UNP's $32M Series A Funding for AI-Driven Macrocycle Drug Development
LongeVC Partakes in UNP's $32 Million Series A Funding, Boosting AI-Driven Macrocycle Innovation for Oncology and Beyond
Announcements
·
2 min
·
Jul 27
Garri Zmudze Speaking at The Asia Summit on Global Health (ASGH) in Hong Kong
Garri Zmudze will attend this year’s Asia Summit on Global Health (ASGH 2024) as a speaker and investor. He will participate in the "New Frontiers in Healthy Ageing" panel.
Announcements
·
4 min
·
Jul 27
Summary of LongeVC’s Investments in Q1 and Q2
As we’re getting to the end of Q2, we prepared a quick summary of all the new additions to LongeVC’s investment portfolio.
Announcements
·
3 min
·
Jul 27
LongeVC’s Q3 & Q4 2024: Investments and Portfolio Updates
LongeVC shares Q3 & Q4 2024 updates, including new investments in Glyphic Bio and Proton Intelligence, as well as key portfolio developments from Turn Bio and Longenesis.
Announcements
·
5 min
·
Jul 27
BioSpectrum: Seeking the 'fountain of youth'
Garri founded the Longevity Science Foundation to fund the diverse treatments contributing to human longevity.
Expert Commentary
·
4 min
·
Jul 27
Load More
LongeVC Backs Interface Biosciences for Advancing Inflammatory Disease Drug Development with AI-Enabled Platform
BioSpectrum: Seeking the 'fountain of youth'
Sifted: Purrsonalised health: The startups and VCs betting on pet genetics